Inspra: new oral aldosterone antagonist coming soonPfizer plans to launch a new aldosterone antagonist, Inspra (eplerenone 25 mg and 50 mg tablets). Weight loss supplements for childhood obesity?Most weight loss supplements should not be recommended for children at this time, according to a recent Canadian review. Ambiguity over value of PSA test persists ARTHROPLASTY: Avoid double knee replacement in patients with heart disease ARTHROPLASTY: Computer-aided knee replacement no better than standard surgery Routine use of time-consuming method appears unwarranted ARTHROPLASTY: Metabolic syndrome raises clot risk after knee replacement Condition's implications just starting to be discussed in orthopedics ARTHROPLASTY: One-in-five 'can't get no' satisfaction from new knee Discuss expectations with patients before surgery, says researcher ARTHROPLASTY: Patients get hip to self-administered rehabilitation Approach equals results from clinics, to which many don't have access anyway ASTHMA & ALLERGIES: Kids' allergies linked to risk of eczema ASTHMA & ALLERGIES: Oral immunotherapy helps allergic kids tolerate peanuts ASTHMA & ALLERGIES: Statins may have role in controlling asthma ASTHMA AND ALLERGIES: New meds, physician awareness credited for gains in asthma care First Previous 1928 1929 1930 1931 1932 Next Last
